Women’s reproductive healthcare in Asia gets a boost with the launch of Yesmom’s at-home blood-testing kit for female fertility in Thailand, designed to help women stay on the front foot of their reproductive health from the comfort of home.
Building on four years of expertise in women’s health, Yesmom is working on becoming the go-to brand in Thailand in the ‘proactive health’ category. With a simple finger-prick, it’s new blood testing kit allows women to receive results on their reproductive health within a few days in an online dashboard that provides clear, comprehensive, clinical-grade insights.
By examining the six fertility hormones Anti-Mullerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Thyroid Stimulating Hormone (TSH), Free Thyroxine (ft4), Prolactin (PRL), and Testosterone (TT), Yesmom’s kit shows how hormone levels can affect egg freezing or IVF, screens for thyroid dysfunction that could negatively impact conception and flags anything that could affect normal ovulation and the fertility window. It also enables women to learn more about menopause and make informed and timed decisions on their reproductive future.
“Women everywhere should have the option to be proactive about their reproductive healthcare,” said Yesmom CEO Peter Macquart-Moulin. “While lab testing for fertility in Asia remains inaccessible to most consumers due to cost and confusing outcomes, we’ve developed an accessible, affordable at-home fertility testing kit that’s easy to use and provides quick results that are simple to understand.”
The test kits are currently available in India and Thailand with further expansion across SE Asia expected before the end of the year.
